Contraindications to metformin therapy in patients with NIDDM

Diabetes Care

Volumn 20, Issue 6, 1997, Pages 925-928

  Sulkin, Thomas V ^a   Bosman, Deborah ^a   Krentz, Andrew J ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; FEMALE; HEART FAILURE; HUMAN; HYPERLACTATEMIA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PROTEINURIA; TREATMENT CONTRAINDICATION;

EID: 0031007415     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.6.925     Document Type: Article

References (24)

1. Bailey CJ: Biguanides and NIDDM. Diabetes Care 15:755-772, 1992
2. Bailey CJ, Turner RC: Metformin. N Engl J Med 334:541-549, 1996
3. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin dependent diabetes mellitus. N Engl J Med 333:550-554, 1995
4. United Kingdom Prospective Diabetes Study (UKPDS): 13. Relative efficacy of randomly allocated diet, sulphonylurea, insulin or metformin in patients with newly diagnosed non-insulin-dependent diabetes followed for three years. BMJ 310:83-88, 1995
5. DeFronzo RA, Goodman AM, the Multicenter Metformin Study Group: Efficacy of metformin in patients with non-insulin dependent diabetes. N Engl J Med 333: 541-549, 1995
6. Bailey CJ, Nattrass M: Treatment - Metformin. Baillières Clin Endocrinol Metab 2:455-476, 1988
7. Nattrass M, Alberti KGMM: Biguanides. Diabetologia 14:71-74, 1978
8. Cohen RD, Woods HF: Clinical and Biochemical Aspects of Lactic Acidosis. Oxford, Blackwell Scientific, 1976
9. Lalau JD, Lacroix C, Compagnon P, De Cagny B, Rigaud JP, Bleichner G, Chauveau P, Dulbecco P, Guerin C, Haegy JM, Loirat P, Marchand B, Ravaud Y, Weyne P, Fournier A: Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 18:779-784, 1995
10. Chalmers J, McBain AM, Brown IRF, Campbell IW: Metformin: is its use contraindicated in the elderly? Pract Diabetes Int 9:51-53, 1992
11. Hart SP, Walker JD: Is metformin contraindicated in diabetic patients with chronic stable heart failure? Pract Diabetes Int 13:18-20, 1996
12. Luft D, Schmulling RM, Eggstein M: Lactic acidosis in biguanide treated diabetics. Diabetologica 14:75-67, 1978
13. Krentz AJ, Ferner RE, Bailey CJ: Comparative tolerability profiles of oral antidiabetic agents. Drug Safety 11:223-241, 1994
14. Somogyi A, Stockley J, Keal P, Rolan P, Bochner F: Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 23:545-551, 1987
15. Cohen RD: Lactic acidosis: new concepts on origins and treatment. Diabetes Rev 2:86-97, 1994
16. DeFronzo RA: Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 3:510-564, 1995
17. Armitage P, Berry G: Statistical Methods in Clinical Research. Oxford, Blackwell Scientific, 1987
18. Hermann LS: Metformin: a review of its pharmacological properties and therapeutic use. Diabete Metab 5:233-245, 1979
19. Wilholm B-E, Myrhed M: Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol 44:589-591, 1993
20. American Diabetes Association: The pharmacological treatment of hyperglycemia in NIDDM (Consensus Statement). Diabetes Care 19 (Suppl. 1):S54-S61, 1996
21. Tymms TJ, Leatherdale BA: Lactic acidosis due to metformin in a low risk patient. Postgrad Med J 64:230-231, 1988
22. Lebovitz HE: Oral antidiabetic drugs. In Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 520-521
23. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
24. Shafer G: Biguanides: a review of history, pharmacodynamics and therapy. Diabetes Metab Rev 9:148-163, 1983